Cetera Investment Advisers grew its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 36.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 9,718 shares of the real estate investment trust’s stock after purchasing an additional 2,583 shares during the period. Cetera Investment Advisers’ holdings in Omega Healthcare Investors were worth $308,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Bronfman E.L. Rothschild L.P. boosted its holdings in shares of Omega Healthcare Investors by 167.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,432 shares of the real estate investment trust’s stock valued at $113,000 after acquiring an additional 2,150 shares in the last quarter. Ffcm LLC boosted its holdings in shares of Omega Healthcare Investors by 197.6% during the 2nd quarter. Ffcm LLC now owns 3,402 shares of the real estate investment trust’s stock valued at $115,000 after acquiring an additional 2,259 shares in the last quarter. Timber Hill LLC acquired a new stake in shares of Omega Healthcare Investors during the 3rd quarter valued at $206,000. Good Life Advisors LLC acquired a new stake in shares of Omega Healthcare Investors during the 3rd quarter valued at $209,000. Finally, HighPoint Advisor Group LLC acquired a new stake in shares of Omega Healthcare Investors during the 3rd quarter valued at $216,000. Institutional investors own 68.14% of the company’s stock.
Several equities research analysts recently weighed in on OHI shares. Zacks Investment Research downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Friday, November 3rd. SunTrust Banks reissued a “hold” rating and set a $30.00 price objective on shares of Omega Healthcare Investors in a report on Wednesday, November 1st. Vetr downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.33 price objective on the stock. in a report on Thursday, October 19th. TheStreet downgraded Omega Healthcare Investors from a “b-” rating to a “c” rating in a report on Monday, October 30th. Finally, Capital One Financial assumed coverage on Omega Healthcare Investors in a report on Monday, October 23rd. They set an “equal weight” rating and a $34.00 target price on the stock. One analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company’s stock. Omega Healthcare Investors presently has a consensus rating of “Hold” and an average target price of $31.83.
Shares of Omega Healthcare Investors, Inc. (OHI) traded down $0.03 on Friday, reaching $27.88. The company’s stock had a trading volume of 2,900,000 shares, compared to its average volume of 2,179,110. The firm has a market cap of $5,530.21, a P/E ratio of 8.21, a PEG ratio of 2.90 and a beta of 0.49. Omega Healthcare Investors, Inc. has a 52-week low of $26.43 and a 52-week high of $35.14. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.40 and a quick ratio of 3.40.
The business also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Tuesday, October 31st were issued a dividend of $0.65 per share. The ex-dividend date of this dividend was Monday, October 30th. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.64. This represents a $2.60 annualized dividend and a yield of 9.33%. Omega Healthcare Investors’s payout ratio is presently 317.08%.
In other Omega Healthcare Investors news, Director Bernard J. Korman acquired 100,000 shares of the company’s stock in a transaction dated Tuesday, October 31st. The shares were bought at an average cost of $28.24 per share, with a total value of $2,824,000.00. Following the purchase, the director now directly owns 903,895 shares of the company’s stock, valued at $25,525,994.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Craig R. Callen acquired 10,000 shares of the company’s stock in a transaction dated Thursday, November 2nd. The stock was acquired at an average cost of $27.38 per share, for a total transaction of $273,800.00. The disclosure for this purchase can be found here. 1.54% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://transcriptdaily.com/2017/12/15/omega-healthcare-investors-inc-ohi-stake-boosted-by-cetera-investment-advisers.html.
Omega Healthcare Investors Profile
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI).
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.